Smallcap stocks have been out of favour this calendar, as investors have offloaded them in hordes amid valuation concerns and earnings disappointments. However, 10 stocks from this segment have swam against the tide and delivered over 100 per cent returns to investors in last six months.
Smallcap pharma company Merck hit an all-time high of Rs 2,666 this week, thus doubling investors’ w ealth in just six months since December 19, 2017. The scrip was hovering around Rs 1,225 in December last year.
Ind-Swift Laboratories is another smallcap pharma firm that has delivered a humungous return to investors in the same period. The stock jumped 156 per cent to trade at Rs 99.80 on June 19 from Rs 38.90 on December 19, 2017.
“We are seeing first signs of limited buying emerging in some of the quality midcap and smallcap stocks, where valuations are now looking reasonable,” Nilesh Shah, MD, Kotak AMC, said ETNow in an interaction.
The BSE Smallcap index has been the worst performers in last six months, falling 10.33 per cent, against a 9 per cent drop in BSE Midcap index and 4 per cent rise in benchmark Sensex.
Among others, IT stock GSS Infotech has rallied 218 per cent in this period, while trading firm Optiemus Infracom has risen 153 per cent.
Best services for customers with full technical support make your Financial Trading more easy click here to subscribe us for free >> Nifty Market Tips
No comments:
Post a Comment